Gates Package — page 1360
of 1375 pages
← p.1359 p.1361 → · this page in the original PDF · package
©
TREAT BY
accomplished in several ways:
+
Method 1: mRNA
vaccine encoding
antigens that induce
immune responses
targeting cells that are
HIV-infected
AND/ OR
*
Method 2: mRNA
vaccine encoding
antibodies optimized to
result in secondary
antiviral immune
responses upon
binding to virus
PARTNERS:
Therapeutic vaccination might be
NXIR)
Mes
VACCINATION
How can mRNA vaccines
and/or BNAbs be engineered to induce
effective antiviral immune responses?
Injection of
mRNA/ LNP
vaccine encodi
Launch one or both approaches
off
an MRNAMlipid nanoparticle
Top - Fab region:
Targeted to "Env" or
another HIV antigen
Bottom - Fc region:
Optimized (upon insertion of
selected mutations) to more
Single-shot mRNA therapeutic
cure for viral infections
potently induce antiviral
immune responses
sy
--
=
'Abbreviations: bNAbs, broadly neutralizing antibodies; ER, endoplasmic reticulum; Fab, "variable" region of antibodies that
confers specific binding to antigens like HIV; Fc, "constant" region of antibodies that confers effector functions; GA, Golgi
apparatus; LNP, lipid nanoparticle
INCENTIVES: Regulatory measures/endpoints for induced antiviral
immune responses, costing infrastructures (to be developed)
EMORY
UNIVERSITY
G if Source: Modema Blog
Not for distribution
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/gates/1360
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| gates:exh:00639 | — | attachment | 1360 |